Scarica l'app Stockscreener
12.40
1.04%
-0.13
Dopo l'orario di chiusura:
12.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.53
Aprire:
$12.56
Volume 24 ore:
1.82M
Relative Volume:
0.94
Capitalizzazione di mercato:
$1.63B
Reddito:
$260.11M
Utile/perdita netta:
$60.64M
Rapporto P/E:
28.84
EPS:
0.43
Flusso di cassa netto:
$92.29M
1 W Prestazione:
+3.42%
1M Prestazione:
+5.98%
6M Prestazione:
+43.02%
1 anno Prestazione:
+79.45%
Intervallo 1D:
$12.36
$12.82
Intervallo di 1 settimana:
$11.57
$12.82
Portata 52W:
$6.42
$12.82
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Nome
Aurinia Pharmaceuticals Inc
Settore
Industria
Telefono
250-744-2487
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Confronta AUPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
12.40 | 1.65B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | H.C. Wainwright | Buy |
| 2022-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-05-05 | Iniziato | Cowen | Outperform |
| 2020-01-10 | Iniziato | Jefferies | Buy |
| 2019-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-16 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Reiterato | FBR & Co. | Outperform |
| 2016-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-08 | Iniziato | MLV & Co | Buy |
Mostra tutto
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Will Aurinia Pharmaceuticals Inc. bounce back from current supportJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
Regression analysis insights on Aurinia Pharmaceuticals Inc. performance2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
How does Aurinia Pharmaceuticals Inc. compare to its peers2025 Geopolitical Influence & Accurate Intraday Trading Signals - خودرو بانک
Real time alert setup for Aurinia Pharmaceuticals Inc. performanceTrend Reversal & Safe Capital Allocation Plans - Newser
Why is Aurinia Pharmaceuticals Inc. stock going downQuarterly Performance Summary & Expert Approved Trade Ideas - خودرو بانک
Is Aurinia Pharmaceuticals Inc. attractive at current valuationVolume Spike & Fast Moving Stock Trade Plans - خودرو بانک
Can machine learning forecast Aurinia Pharmaceuticals Inc. recoveryEarnings Growth Report & Weekly Breakout Stock Alerts - Newser
Analyzing Aurinia Pharmaceuticals Inc. with risk reward ratio charts2025 Winners & Losers & Free Community Supported Trade Ideas - Newser
Quantitative breakdown of Aurinia Pharmaceuticals Inc. recent move2025 Performance Recap & Advanced Technical Analysis Signals - Newser
Evaluating Aurinia Pharmaceuticals Inc. with trendline analysisPortfolio Growth Summary & Smart Money Movement Tracker - Newser
Using economic indicators to assess Aurinia Pharmaceuticals Inc. potential2025 Trade Ideas & High Win Rate Trade Tips - Newser
Can a trend reversal in Aurinia Pharmaceuticals Inc. lead to recoveryWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser
Dow Update: What are Aurinia Pharmaceuticals Inc.’s technical support levelsMarket Growth Summary & Real-Time Stock Movement Alerts - خودرو بانک
Full technical analysis of Aurinia Pharmaceuticals Inc. stockWeekly Profit Report & Verified Stock Trade Ideas - Newser
Aurinia Pharmaceuticals stock hits 52-week high at 12.55 USD - Investing.com
Will Aurinia Pharmaceuticals Inc. face regulatory challengesDay Trade & Verified Technical Signals - خودرو بانک
What Fibonacci levels say about Aurinia Pharmaceuticals Inc. rebound2025 Market Overview & Real-Time Volume Analysis Alerts - Newser
Advanced analytics toolkit walkthrough for Aurinia Pharmaceuticals Inc.Bond Market & Smart Investment Allocation Insights - Newser
How to integrate Aurinia Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Applying Elliott Wave Theory to Aurinia Pharmaceuticals Inc.July 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser
Can Aurinia Pharmaceuticals Inc. hit a new high this monthTrade Volume Summary & Daily Chart Pattern Signals - Newser
Is Aurinia Pharmaceuticals Inc. showing insider buyingTrade Volume Report & Stock Timing and Entry Methods - خودرو بانک
How sentiment analysis helps forecast Aurinia Pharmaceuticals Inc.July 2025 Catalysts & Smart Allocation Stock Reports - Newser
Can Aurinia Pharmaceuticals Inc. grow without external fundingWeekly Stock Report & Weekly High Conviction Ideas - خودرو بانک
Visual analytics tools that track Aurinia Pharmaceuticals Inc. performanceJuly 2025 Setups & Daily Volume Surge Trade Alerts - Newser
Should I set a stop loss on Aurinia Pharmaceuticals Inc.Earnings Trend Report & Fast Exit and Entry Strategy Plans - خودرو بانک
Nephrotic Syndrome Pipeline Analysis, 2025 by DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squibb, ChemoCentryx, SynAct Pharm - Barchart.com
Will Aurinia Pharmaceuticals Inc. benefit from government policyWeekly Market Report & Free Technical Pattern Based Buy Signals - خودرو بانک
Is Aurinia Pharmaceuticals Inc. gaining market share2025 Top Decliners & Low Risk High Win Rate Stock Picks - خودرو بانک
What is Aurinia Pharmaceuticals Inc.’s market position2025 Market WrapUp & Verified Momentum Watchlists - خودرو بانک
Aurinia Pharmaceuticals Inc. stock trend outlook and recovery pathBond Market & Weekly Momentum Stock Picks - Newser
Published on: 2025-09-02 04:45:19 - Newser
Multi factor analysis applied to Aurinia Pharmaceuticals Inc.July 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
What are Aurinia Pharmaceuticals Inc.’s technical support levelsCPI Data & Daily Entry Point Trade Alerts - خودرو بانک
Can Aurinia Pharmaceuticals Inc. sustain earnings growthMarket Sentiment Summary & Weekly Breakout Stock Alerts - خودرو بانک
What makes Aurinia Pharmaceuticals Inc. stock attractive today2025 Top Decliners & Real-Time Price Movement Reports - خودرو بانک
Does Aurinia Pharmaceuticals Inc. offer margin of safetyMarket Risk Analysis & Real-Time Price Movement Reports - خودرو بانک
Aurinia Pharmaceuticals Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Aurinia Pharmaceuticals Inc. forming a bottoming baseTrade Volume Summary & Weekly High Momentum Picks - Newser
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):